LONG-TERM OUTCOMES AFTER NUCLEOS(T)IDE ANALOGUES DISCONTINUATION IN CHRONIC HEPATITIS B PATIENTS WHO ARE HBeAg-POSITIVE

被引：0
|
作者：
He, D. [1 ,2 ]
Tao, S. [1 ]
Guo, S. [1 ]
Wang, Y. [1 ]
Ding, M. [2 ]
机构：
[1] Third Mil Med Univ, Chongqing, Peoples R China
[2] Chinese PLA, Hosp 88, Tai An, Shandong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)61256-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1096
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [1] Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients
    He, D.
    Guo, S.
    Zhu, P.
    Tao, S.
    Li, M.
    Huang, H.
    Wang, J.
    Wang, Y.
    Ding, M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : O687 - O693
  • [2] Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative
    He, Dengming
    Guo, Shimin
    Chen, Wen
    Chen, Xianli
    Yan, Guohua
    Wang, Jie
    Li, Maoshi
    Zhu, Peng
    Huang, Hongfei
    Wang, Yuming
    [J]. BMC INFECTIOUS DISEASES, 2013, 13
  • [3] Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative
    Dengming He
    Shimin Guo
    Wen Chen
    Xianli Chen
    Guohua Yan
    Jie Wang
    Maoshi Li
    Peng Zhu
    Hongfei Huang
    Yuming Wang
    [J]. BMC Infectious Diseases, 13
  • [4] Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues
    Leung, Nancy
    [J]. LIVER INTERNATIONAL, 2011, 31 : 85 - 89
  • [5] A novel nomogram for predicting HBeAg clearance in HBeAg-positive chronic hepatitis B patients after nucleos (t)ide analogues treatment
    Gu, Yan
    Wang, Jian
    Zhang, Zhiyi
    Zhang, Shaoqiu
    Zhang, Yao
    Ding, Weimao
    Li, Jie
    Huang, Rui
    Wu, Chao
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S1128 - S1129
  • [6] A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues
    Gu, Yan
    Zhang, Yao
    Zhang, Zhiyi
    Wang, Jian
    Zhang, Qing
    Zhang, Shaoqiu
    Liu, Yilin
    Liu, Jiacheng
    Xia, Juan
    Yan, Xiaomin
    Li, Jie
    Liu, Xingxiang
    Huang, Rui
    Wu, Chao
    [J]. ANNALS OF HEPATOLOGY, 2024, 29 (01)
  • [7] Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analogues
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Kourikou, Anastasia
    Deutsch, Melanie-Maria
    Triantos, Christos
    Tsolias, Chrysostomos
    Manesis, Emanuel K.
    Mathou, Nicoletta
    Alexopoulou, Alexandra
    Hadziyannis, Emilia
    Papatheodoridis, George
    [J]. LIVER INTERNATIONAL, 2021, 41 (01) : 48 - 57
  • [8] Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits
    Korkmaz, Pinar
    Demirtuerk, Nese
    [J]. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2024, 6 (02): : 70 - 77
  • [9] High relapse rates in HBeAg negative chronic hepatitis B patients after discontinuation of nucleos(t)ide analogues
    Hansen, Bettina E.
    Cornberg, Markus
    Chan, Henry Lik-Yuen
    Arends, Pauline
    Wiegand, Steffen B.
    Brunetto, Maurizia R.
    Janssen, Harry L.
    [J]. HEPATOLOGY, 2012, 56 : 412A - 412A
  • [10] TREATMENT OF HBEAG-POSITIVE CHRONIC DELTA HEPATITIS WITH NUCLEOS(T)IDE ANALOGS
    Yurdaydin, Cihan
    Bozkaya, Hakon
    Heidrich, Benjamin
    Cakalogu, Yilmaz
    Deterding, Katja
    Akarca, Ulus S.
    Tillmann, Hans L.
    Uzunalimoglu, Ozden
    Bozdayi, A. Mithat
    Manns, Michael P.
    Wedemeyer, Heiner
    [J]. HEPATOLOGY, 2008, 48 (04) : 722A - 722A
12345